Amiselimod
Moderate to Severe Ulcerative Colitis
Phase 2Uncertain/Stalled
Key Facts
Indication
Moderate to Severe Ulcerative Colitis
Phase
Phase 2
Status
Uncertain/Stalled
Company
About Bausch Health
Bausch Health is a restructured specialty pharma company with a mission to enrich lives through better health outcomes in key therapeutic areas. Its strategy centers on acquiring and in-licensing commercial-stage assets, followed by aggressive lifecycle management to extend product value. The company has successfully separated its eye health business (Bausch + Lomb) and is now focused on core segments in GI, aesthetics, and international markets, while navigating a significant debt burden.
View full company profile